针对新型信号通路的治疗潜力,用于调节阻塞性肺部疾病中的慢性炎症
Dan Li1, Ana L Manzano-Covarrubias1, Kelly B I Douglas2
1Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Pharmacology & therapeutics
|January 21, 2026
概括
慢性阻塞性肺病 (COPD) 和喘涉及持续的呼吸道炎症. 本综述详细介绍了这些阻塞性肺部疾病的不同炎症概况,感染影响,当前治疗方法和新型治疗点.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 和喘的特点是持续的呼吸道炎症和逐渐下降的肺功能.
- 慢性肺炎涉及中性恋炎症,而喘与乙酸和T助手2 (Th2) 介导的反应有关.
- 在这两种情况下,感染显著加剧了炎症和肺损伤.
研究的目的:
- 探索COPD和喘中慢性炎症的机制.
- 评估当前的治疗方法及其局限性.
- 确定阻塞性肺部疾病的新型治疗点.
主要方法:
- 审查关于COPD和喘炎症的现有文献.
- 分析感染对炎症反应的影响.
- 评估当前和新兴的治疗策略.
- 讨论呼吸道炎症中的关键信号通路.
主要成果:
- 明显的炎症概况区分了COPD和喘.
- 感染会加剧炎症和肺部损伤.
- 目前的治疗方法 (皮质类固醇,支气管扩展剂,生物药物) 有局限性.
- 关键的信号通路 (NF-κB,CXCR2,TLRs,TNF,P2X4受体,NLRP3炎症体) 在维持炎症方面至关重要.
结论:
- 了解不同的炎症机制和信号通路对于开发向治疗至关重要.
- 新型治疗点为慢性气道炎症的革命性治疗策略提供了潜在的潜力.
- 对这些途径的进一步研究可以改善阻塞性肺部疾病的管理.
相关概念视频
Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Notch Signaling Pathway
6.5K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway
9.9K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K


